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INTRODUCTION
Congenital heart disease (CHD) occurs in nearly 1% of all live
births and is the leading cause of infant mortality and morbidity in
the western world. Persistent truncus arteriosus (PTA) is the most
severe phenotype of outflow tract (OFT) defects, with an
unfavorable prognosis as surgical repair is not always possible
(Williams et al., 1999). Although discovering the genetic causes
would provide insight into the pathogenesis of CHD, the etiology of
most human CHD, including OFT defects, remains unknown
because of the multifactorial nature of the diseases, indicating the
need for more study (Bruneau, 2008; Olson, 2006; Yamagishi et al.,
2009; Zhao and Srivastava, 2007).
The OFT is derived from the second heart field (SHF), with a
major contribution from cardiac neural crest (CNC) (Diman et al.,
2011). The OFT, which first forms as a single tube, separates into
the aorta and pulmonary trunk through both epithelial to
mesenchymal transition (EMT) proximally and CNC influx into
distal OFT. Endocardial cells in the proximal OFT undergo EMT
and contribute to the proximal OFT cushions and to a subset of cells
within semilunar valves. Defects in EMT and CNC influx are
associated with several CHDs. During OFT development,
endocardial cells sense and respond to inductive signals from
overlying myocardium and initiate the process of EMT to contribute
to conotruncal cushions. Several genes have been shown to regulate
EMT, including Twist1, Snai1 and Slug (Snai2) (Ma et al., 2005;
Niessen et al., 2008; Yang et al., 2004).
Other studies show that Bmp signals are required for OFT
morphogenesis (Liu et al., 2004; Ma et al., 2005; McCulley et al.,
2008). Bmp2 is involved in EMT during atrioventricular (AV)
cushion development (Ma et al., 2005), whereas Bmp4 is crucial for
OFT separation and cushion development (Liu et al., 2004;
McCulley et al., 2008). Bmp4 mutant embryos show variability in
phenotype with incomplete penetrance, possibly owing to the
functional redundancy of Bmp ligands. Although ablation of Bmp7
has no obvious phenotypic consequences in the heart (Solloway and
Robertson, 1999), loss of Bmp4 causes upregulation of Bmp7 in
OFT myocardium and compound mutants have a more severe
phenotype (Liu et al., 2004). The overlapping expression of Bmp
ligands in the OFT and their redundancy in function makes
functional analysis of Bmp ligands in OFT development
challenging.
Bmp signaling is transduced through a canonical pathway
involving phosphorylation of Smad1/5/8 (R-Smad) from the ligand-
receptor complex. Phosphorylated R-Smads then form a complex
with Smad4 (Co-Smad) and this complex shuttles from cytoplasm
to nucleus. Since Smads bind DNA motifs with low affinity and
selectivity (Itoh et al., 2000; Karaulanov et al., 2004; Shi and
Massagué, 2003; Zwijsen et al., 2003) they associate with various
transcription factors to bind DNA and promote or repress
transcription (Kawabata et al., 1998; Zwijsen et al., 2003).
Recent studies have shown that Bmp signaling also regulates
downstream genes through microRNA (miRNA) maturation. In
vascular smooth muscle, TGFβ- and Bmp-specific Smads are
recruited to the p68 (Ddx5) RNA helicase-containing complex. The
Smad-p68 complex interacts with the miRNA processing enzyme
Drosha in the nucleus to regulate the biogenesis of a subset of
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SUMMARY
Congenital heart disease (CHD) is a devastating anomaly that affects ~1% of live births. Defects of the outflow tract (OFT) make up
a large percentage of human CHD. We investigated Bmp signaling in mouse OFT development by conditionally deleting both Bmp4
and Bmp7 in the second heart field (SHF). SHF Bmp4/7 deficiency resulted in defective epithelial to mesenchymal transition (EMT) and
reduced cardiac neural crest ingress, with resultant persistent truncus arteriosus. Using a candidate gene approach, we found that
Vegfa was upregulated in the Bmp4/7 mutant hearts. To determine if Vegfa is a downstream Bmp effector during EMT, we examined
whether Vegfa is transcriptionally regulated by the Bmp receptor-regulated Smad. Our findings indicate that Smad directly binds to
Vegfa chromatin and represses Vegfa transcriptional activity. We also found that Vegfa is a direct target for the miR-17-92 cluster,
which is also regulated by Bmp signaling in the SHF. Deletion of miR-17-92 reveals similar phenotypes to Bmp4/7 SHF deletion. To
directly address the function of Vegfa repression in Bmp-mediated EMT, we performed ex vivo explant cultures from Bmp4/7 and miR-
17-92 mutant hearts. EMT was defective in explants from the Bmp4/7 double conditional knockout (dCKO; Mef2c-Cre;Bmp4/7f/f) and
miR-17-92 null. By antagonizing Vegfa activity in explants, EMT was rescued in Bmp4/7 dCKO and miR-17-92 null culture. Moreover,
overexpression of miR-17-92 partially suppressed the EMT defect in Bmp4/7 mutant embryos. Our study reveals that Vegfa levels in
the OFT are tightly controlled by Smad- and microRNA-dependent pathways to modulate OFT development.
KEY WORDS: Bone morphogenetic protein, microRNA, Vascular endothelial growth factor A, Epithelial to mesenchymal transition,
Outflow tract, Mouse
Bmp signaling represses Vegfa to promote outflow tract
cushion development












miRNAs, including miR-21 (Davis et al., 2008). During cardiac
development, Bmp2/4 regulate OFT myocardial differentiation by
promoting Smad-mediated transcription of the miR-17-92 cluster
(Wang et al., 2010). The miR-17-92 cluster, which encodes miR-
17, miR-18a, miR-19a, miR-20a, miR-19b-1 and miR-92-1, is
oncogenic and also functions in the development of the heart, lungs
and immune system (Koralov et al., 2008; Ventura et al., 2008;
Vincentz et al., 2008; Xiao et al., 2008).
In this study, we discovered that loss of Bmp4/7 in the SHF
resulted in PTA with upregulation of Vegfa, repression of which is
required in the atrioventricular canal (AVC) to promote EMT
(Chang et al., 2004). Our in vitro studies showed that Vegfa is
repressed by both Smad and miR-17/20a. Moreover, in vivo and ex
vivo studies showed that overexpression of miR-17-92 or repression
of Vegfa can partially suppress the Bmp loss-of-function phenotype.
Our study reveals that in the OFT, EMT and CNC influx are




The Bmp4 flox, miR-17-92 null and miR-17-92OE alleles and Mef2c-Cre
lines have been described previously (Liu et al., 2004; Ventura et al., 2008;
Verzi et al., 2005; Xiao et al., 2008). To generate the Bmp7 flox allele, a
targeting vector was constructed that introduced one loxP site upstream of
Bmp7 exon 4 followed by an FRT-flanked PGKneo cassette, while another
loxP site was introduced downstream of Bmp7 exon 4 (see supplementary
material Fig. S1). 
β-galactosidase staining, histology and immunostaining
Embryos were fixed overnight in 4% paraformaldehyde or buffered
formalin, dehydrated through a graded ethanol series, and paraffin
embedded. Sections were cut at 7 µm and used for Hematoxylin and Eosin
(H&E) staining or immunostaining. Detection of lacZ expression on whole
embryos was performed as previously described (Lu et al., 1999). For
Twist1 immunodetection, sections were deparaffinized and hydrated. For
antigen retrieval, 10 mM citrate buffer was used. Monoclonal anti-Twist1
(Abcam, ab50887; 1:200) was used as primary antibody. HRP-conjugated
anti-mouse secondary antibody (Bio-Rad) was visualized using TSA Plus
Fluorescence Systems (PerkinElmer). Nuclei were stained with 4,6-
diamidino-2-phenylindole dihydrochloride (DAPI) (Invitrogen).
Quantitative real-time RT-PCR
Total RNA from OFT (E10.5 embryos) was isolated using the RNeasy
Micro Kit (Qiagen). SuperScript II reverse transcriptase (Invitrogen) was
used for reverse transcription (RT)-PCR with 20-100 ng mRNA and SYBR
Green JumpStart Taq ReadyMix (Sigma) in triplicate reactions on a
StepOnePlus Real-Time PCR System (ABI); Gapdh was used as internal
control. Vegfa was detected by TaqMan probe (IDT, Mm.PT.47.7135538.g)
with 18s rRNA (IDT) as internal control. For miRNAs, TaqMan MicroRNA
Assay Kits (Applied Biosystems) were used according to the manufacturer’s
guidelines. Sno-202 was used as internal control. For all qRT-PCR
experiments, at least four mutant and four control embryos were analyzed.
All error bars represent s.e.m. Primer sequences are available in
supplementary material Table S1.
Sequence analysis and miRNA target prediction
For sequence analysis and alignment, NCBI (http://www.ncbi.nlm.nih.gov/),
Ensemble (http://uswest.ensemble.org/index.html), rVista 2.0
(http://rvista.dcode.org/) and TFSEARCH (http://mbs.cbrc.jp/research/db/
TFSEARCH.html) were used. For miRNA target prediction, miRanda
(http://www.microrna.org), TargetScan (http://www.targetscan.org) and
miRDB (http://mirdb.org/miRDB/) were used.
Generation of constructs
To generate the Vegfa promoter luciferase reporter plasmid, a 1563 bp
fragment of the mouse Vegfa promoter was amplified using a high-fidelity
PCR system (Roche) and subcloned into the pGL3-Basic vector (Promega).
To generate the Vegfa 3UTR luciferase reporter plasmid, 1881 bp of Vegfa
3UTR genomic sequence was amplified using the high-fidelity PCR system
from a cDNA clone (#6816435, Open Biosystems) and subcloned into the
pMIR-REPORT Luciferase miRNA Expression Reporter Vector (Ambion).
Site-directed mutagenesis of the seed sites in the Vegfa 3UTR and Vegfa
promoter was performed with the QuickChange II Site-Directed Mutagenesis
Kit (Stratagene). Primers are listed in supplementary material Table S1.
Luciferase activity assay
P19 cells were transfected with the Vegfa promoter and 3UTR reporter
plasmids described above using Lipofectamine 2000 (Invitrogen).
Luciferase activity assays were performed using the Dual-Luciferase
Reporter Assay System (Promega). The Renilla luciferase-encoding plasmid
pRL-TK was used as the normalization control. Ca-Alk3 (Wang et al., 2010)
was used to activate the Smad pathway. miRNA mimics were purchased
from Thermo Scientific.
Ex vivo OFT explant culture
A solution (1.5 mg/ml) of rat tail collagen type I (BD Biosciences) was
dispensed into 24-well microculture dishes and allowed to solidify in a
37°C, 5% CO2 incubator. Collagen gels were washed several times with
DMEM containing 10% fetal bovine serum (FBS), 0.1% insulin-transferrin-
selenium (ITS, Gibco, Invitrogen) and 100 unit/ml penicillin, 100 μg/ml
streptomycin (1:100, penicillin-streptomycin solution, Hyclone, Thermo
Scientific). OFTs were harvested in sterile Tyrode’s Salt Solution (Sigma-
Aldrich) from E10.5 embryos. OFTs were carefully dissected, and
endocardium was exposed to the collagen gel, with the myocardium
overlaying. Four hours after attachment, medium (100 μl/well) was added
and explants cultured for up to 3 days. Explants were fixed and stained with
anti-alpha-SMA-Cyan3 (1:100; Sigma-Aldrich) to detected mesenchymal
cells and phalloidin-FITC (1:100; Sigma-Aldrich) to reveal the actin
cytoskeleton as described (Luna-Zurita et al., 2010). TO-PRO-3 Iodide
(TOP3; Invitrogen) was used for nuclei staining. For explant treatments,
the medium was supplemented with sFlt (10 ng/ml; R&D Systems, 471-
F1). Medium was replaced every 24 hours.
In vivo chromatin immunoprecipitation
About 80 OFTs of E10.5 wild-type embryos were dissected and subjected
to chromatin immunoprecipitation (ChIP) analysis. Soluble chromatin was
prepared after formaldehyde crosslinking and sonication. Smad1/5/8
antibody (sc-6031 X, Santa Cruz) was used to immunoprecipitate protein-
bound DNA fragments; rabbit IgG was used as control. The PCR products
for the SBE1, SBE2 and SBE3 fragments are 280 bp, 402 bp and 204 bp,
respectively. Primers that amplified sequence irrelevant for Smad binding
were used as a negative control. SYBR Green was used for ChIP-qPCR,
and results were analyzed by the percentage input method (Invitrogen).
Primer sequences are available in supplementary material Table S1.
RESULTS
Bmp2, Bmp4 and Bmp7 regulate EMT and have
redundant functions
Bmp2, Bmp4 and Bmp7 show overlapping expression patterns and
functional redundancy (Bonilla-Claudio et al., 2012; Dudley and
Robertson, 1997; Furuta et al., 1997; Wang et al., 2010). We
compared their expression patterns using lacZ knock-in mouse lines
for Bmp2 and Bmp4 and in situ hybridization of Bmp7. Bmp2 and
Bmp4 were expressed in the OFT at E9.5, whereas Bmp7 was
broadly expressed throughout the heart tube (supplementary
material Fig. S2A,B,G,H,M,N). Bmp4 expression was found in the
inflow tract at E9.5, but was limited to the OFT at E10.5. Analysis
of the sections revealed that Bmp2, Bmp4 and Bmp7 were
exclusively co-expressed in OFT myocardium (supplementary
material Fig. S2C,E,I,L,O,R). At E10.5, expression of Bmp2 in the
OFT was decreased (supplementary material Fig. S2G,J), whereas
Bmp4 and Bmp7 expression was maintained at similar levels
(supplementary material Fig. S2A,D,M,P).











To examine functional redundancy, we deleted Bmp2, Bmp4 and
Bmp7 in different combinations in the OFT using Mef2c-Cre (Fig. 1A-
H). Proximal OFT mesenchymal cells were absent from Bmp2/4,
Bmp4/7 and Bmp2/7 double conditional knockout (dCKO) embryos
(Fig. 1C-F). Bmp4/7 deletion resulted in OFT cushion defects in CNC-
derived distal OFT, as well as proximal OFT (Fig. 1D). The distal
OFT defects were not observed upon deleting Bmp2 in a Bmp4
homozygous or heterozygous background, suggesting that Bmp2 has
limited function in the OFT proper (Fig. 1C,F).
Consistent with the defective CNC influx and proximal EMT
observed at E10.5, Bmp4/7 mutants had severe OFT defects at
E14.5, with failure of OFT separation resulting in PTA (Table 1,
Fig. 1I-L). One Bmp4/7 dCKO embryo had double outlet right
ventricle (DORV), with both aortic and pulmonary arteries draining
the right ventricle (Table 1). In addition to defective great vessel
separation, histological sections revealed hypoplastic semilunar
valves and an interventricular septal defect (VSD; data not shown)
in the Bmp4/7 dCKO (Fig. 1J,L). Taken together, our findings
revealed that Bmp4 and Bmp7 have redundant functions in OFT
development. To further explore Bmp signaling in the OFT, we
focused on the Bmp4/7 dCKO mouse model.
To investigate EMT in the Bmp4/7 dCKO, we performed
phosphohistone H3 (pHH3) analysis for cell proliferation and did
not observe any obvious difference between the control and Bmp4/7
dCKO in the myocardium (data not shown). Immunostaining
showed fewer Twist1-expressing mesenchymal cells in the OFT of
the Bmp4/7 dCKO than the control (Fig. 1M,N), indicating that
fewer cells progressed through EMT in the Bmp4/7 mutant. To
determine the mechanism of EMT regulation by Bmp, the
expression of genes involved in the Bmp pathway and EMT was
examined by qRT-PCR. The Bmp-regulated EMT genes Snai1,
Slug, Id1 and Id2 were significantly decreased in the Bmp4/7 dCKO
OFT, whereas Vegfa was upregulated 1.8-fold (Fig. 1O).
Smad directly represses Vegfa transcription
The major downstream Bmp signaling effectors are Smad proteins.
To determine whether Vegfa is a direct downstream target of Bmp,
we searched for conserved Smad binding sites in Vegfa upstream
sequences by bioinformatics analysis. Analysis of Vegfa upstream
sequence predicted several conserved functional elements for the
Bmp response (McCulley et al., 2008), comprising Smad binding
elements (SBEs) and the Smad1 binding motif (s1). The SBE is a
canonical Smad binding sequence (Shi et al., 1998) that is found in
the promoter of many TGFβ- and Bmp-responsive genes, whereas
the s1 motif is found in the promoter of Xenopus vent2. These motifs
are usually flanked by Bmp responsive element (BRE)-like and/or
GC-rich boxes (Fig. 2A), which are common in the regulatory
elements of Bmp-responsive genes. To test whether Smad directly
binds Vegfa upstream sequences, we performed in vivo chromatin
immunoprecipitation (ChIP)-PCR analysis on wild-type E10.5 OFT.
We detected enrichment in the anti-Smad1/5/8 ChIP-PCR for all
three putative SBEs (Fig. 2B,C). ChIP-qPCR data further supported
that these putative SBEs were bound by Smad in Vegfa chromatin
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Fig. 1. Inactivation of Bmp2, Bmp4 and Bmp7 in the
SHF. (A-H) Hematoxylin and Eosin-stained sagittal
sections of E10.5 mouse embryos with different
combinations of Bmp gene deletion. The Bmp genes were
knocked out conditionally in the second heart field (SHF)
using Mef2c-Cre. Black arrowheads indicate proximal
outflow tract (OFT) and white arrowheads distal OFT. For
A-H, n=6, 5, 5, 6, 3, 2, 5, 5. (I-L) Whole-mount (I,K) and
sections (J,L) of control and Bmp4/7 dCKO hearts at E14.5.
The arrowhead in K indicates persistent truncus arteriosus
(PTA). ba, branchial arch; m, myocardium; mc,
mesenchymal cushion; e, epithelium; ao, aorta; pa,
pulmonary artery; la, left atrium; ra, right atrium; lv, left
ventricle; rv, right ventricle; av, aorta valve; sv, semilunar
valve; pta, persistent truncus arteriosus; ivs, interventricular
septum. (M,N) Immunostaining of Twist1 in control and
Bmp4/7 dCKO embryos at E10.5. Arrowheads point to
Twist1-positive cells. (O) The expression of EMT-related
genes was examined in the OFT of control and Bmp4/7
dCKO embryos at E10.5. RT-PCR analysis was performed
using SYBR Green for Id1/2, Snai1 and Slug and TaqMan for
Vegfa. Control, n=5; mutant, n=4. Error bars represent
s.e.m. *P<0.004, **P=0.03, ***P=0.04 (two-tailed t-test).
Scale bars: 100 μm in A-I,K; 500 μm in J,L; 50 μm in M,N.
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(Fig. 2C). These results indicate that Smad1/5/8 can directly bind
Vegfa chromatin in the OFT.
To determine whether Smad directly regulates Vegfa
transcription, we cloned a ~1500 bp region upstream of Vegfa and
generated a luciferase reporter (Fig. 2D). To activate the Smad-
dependent Bmp pathway, we co-transfected a constitutively active
form of the type 1 Bmp receptor Alk3 (ca-Alk3) into the mouse P19
cell line (Wang et al., 2010) (Alk3 is also known as Bmpr1a –
Mouse Genome Informatics). Luciferase assays demonstrated that
Vegfa promoter activity was significantly diminished, by 35%, in
the presence of ca-Alk3 (Fig. 2E). To determine whether Vegfa
promoter repression was due to direct Smad binding, we introduced
mutations into the predicted Smad binding sites (Fig. 2D).
Mutations in SBE1, SBE2 and/or SBE3 resulted in loss of
repression by Bmp signaling (Fig. 2E), showing that Smad directly
binds these sites and represses Vegfa. Mutation in s1 did not affect
luciferase activity (Fig. 2E), suggesting that this motif is not
necessary in repressing Vegfa. These results indicated that Smad can
directly repress Vegfa transcription, but by only 35%. Since loss of
Bmp4/7 resulted in a 175% increase in Vegfa levels, there might be
other important Smad elements that are excluded from our
luciferase reporter or other Bmp downstream effector mechanisms
that contribute to Vegfa regulation.
miR-17 and miR-20a are downstream effectors of
Bmp in Vegfa repression
Our results raise the possibility that Vegfa levels are regulated by
mechanisms other than direct Smad binding to Vegfa chromatin.
Alternative downstream Bmp effectors include miRNAs, which are
involved in the refinement of gene expression. miR-17-92 is
downstream of the Bmp pathway in cardiac development (Wang et
al., 2010). Bioinformatic analysis predicted a highly conserved miR-
17/20a binding site in the 3UTR of Vegfa (Fig. 3A). The levels of
pri-miR-17-92 and mature miR-17/20a were decreased in the OFT
of Bmp4/7 dCKO embryos (Fig. 3B), showing that miR-17/20a are
downstream of Bmp4/7.
To determine the role of miR-17-92 during OFT development,
we analyzed miR-17-92 null (miR-17-92N/N) embryos. At E10.5,
miR-17-92N/N embryos showed OFT defects, including lack of
mesenchymal cushion formation (Fig. 3C,D). miR-17-92N/N
embryos developed no mesenchymal cells in either the proximal or
distal OFT, resembling the phenotype of the Bmp4/7 dCKO. At
E14.5, miR-17-92N/N embryos exhibited the DORV phenotype,
together with abnormal semilunar valve and VSD (Fig. 3E,F).
Notably, loss of miR-17-92 resulted in a 1.7-fold increase in the
level of Vegfa (Fig. 3G). This upregulation of Vegfa is similar to that
observed in the Bmp4/7 dCKO (Fig. 1O). Taken together, our results
suggest that miR-17-92 is downstream of Bmp signaling during
EMT in the OFT.
To determine whether Vegfa can be regulated by miR-17 and
miR-20a, we cloned 1874 bp of the native Vegfa 3UTR and
constructed a luciferase reporter vector (Fig. 3H). Co-transfection
with miR-17/20a resulted in suppression of the Vegfa 3UTR
reporter (Fig. 3I), whereas miR-92a did not suppress the luciferase
activity. Then we mutated the miR-17/20a binding site in the Vegfa
3UTR (Fig. 3H). Suppression by both miR-17 and miR-20a was
abolished in the mutated Vegfa reporter (Fig. 3I), showing that the
putative miR-17/20a site was responsible for 3UTR silencing of
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Fig. 2. Transcriptional modulation of Vegfa by Smad.
(A) Putative transcription factor/Smad binding sites in the
Vegfa upstream sequence from mouse (Mmu), human
(Hsa), chimpanzee (Ptr), rat (Rno) and rabbit (Ocu).
Mutations introduced into the Vegfa promoter in the
luciferase reporters are shown in red. (B) Vegfa upstream
sequence illustrating the positions of ChIP primers
(arrows). s1, Smad1 binding motif; SBE, Smad binding
element. (C) In vivo ChIP indicates that Smad is bound to
Vegfa chromatin. DNA from wild-type OFT was
immunoprecipitated with antibody against Smad1/5/8.
Non-specific rabbit IgG was used as negative control. Non-
immunoprecipitated DNA (10% input) was used as
positive control. PCR analysis employed the primer sets
shown in B. ddH2O, PCR in the absence of template DNA.
The bar chart shows the percentage input
immunoprecipitated by IgG and anti-Smad as assessed by
ChIP-qPCR. Each sample is in triplicate. (D) Native and
mutated Vegfa reporter constructs. (E) Luciferase assay.
Native and mutated Vegfa reporter constructs were
transfected with or without the constitutively active ca-
Alk3 construct. *P=0.011, **P=0.009 (two-tailed t-test). All











Vegfa. These results strongly suggest that miR-17/20a are
downstream effectors of Bmp4/7 in repression of Vegfa.
Repression of Vegfa regulates EMT during OFT
development
Vegfa is known to inhibit mesenchymal transformation in the AV
cushion (Chang et al., 2004); however, the potential roles of Vegfa
in EMT during Bmp-mediated OFT development have not been
investigated. To determine if Bmp regulates EMT through Vegfa
repression, we investigated whether reducing Vegfa can rescue the
EMT defect caused by Bmp4/7 deletion. We performed ex vivo
analysis by culturing the OFT from E10.5 embryos on collagen
gel, with the endocardium exposed to the gel (Fig. 4A). In control
explants, a halo of mesenchymal cells formed around the
myocardium, with non-invasive mesenchymal cells on the surface
of the gel and invasive mesenchymal cells invading the collagen
depths (Fig. 4B,C). In the OFT of the Bmp4/7 dCKO, both
invasive and non-invasive EMT were absent (Fig. 4D,E).
Administration of sFlt (Flt1 – Mouse Genome Informatics), a
soluble Vegfa antagonist, partially suppressed the mesenchymal
transformation defect in the Bmp4/7 dCKO by rescuing non-
invasive mesenchyme cell formation (Fig. 4F). Invasive EMT was
not rescued by antagonizing Vegfa (Fig. 4G), suggesting that this
process is regulated by other downstream Bmp targets, such as
Snai1.
Next, to determine whether miR-17 and miR-20a regulate EMT
through Vegfa, we performed explant culture from miR-17-92N/N
OFT (Fig. 4H,I). The OFT from the miR-17-92 null lacked both
invasive and non-invasive EMT (Fig. 4H,I), recapitulating the
explant from the Bmp4/7 dCKO (Fig. 4D). After addition of the
Vegfa antagonist sFlt to the explant, both the non-invasive and
invasive EMT processes were rescued in the miR-17-92N/N explants
(Fig. 4J,K), showing that Vegfa downregulation was sufficient to
rescue the miR-17-92 loss-of-function phenotype. Since
antagonizing Vegfa was not sufficient to rescue invasive EMT in
the explant from the Bmp4/7 dCKO (Fig. 4G), regulation of Vegfa
by miR-17-92 must be just one of multiple downstream effectors
of Bmp signaling.
miR-17-92 can rescue defects in EMT caused by
loss of Bmp
To address the hypothesis that miR-17/20a are direct downstream
effectors of Bmp in the EMT process in vivo, we overexpressed
miR-17-92 in the Bmp4/7 dCKO by crossing miR-17-92OE/+ (Xiao
et al., 2008) and Mef2c-Cre lines. qRT-PCR data showed that miR-
17 and miR-20a were mildly elevated, by ~1.3-fold, in the OFT of
Mef2c-Cre;miR-17-92OE/+ embryos (Fig. 5A). Vegfa levels were
moderately downregulated in the OFT of Mef2c-Cre;miR-17-92OE/+
(Fig. 5A), demonstrating that miR-17-92 represses Vegfa in vivo.
To determine whether miR-17-92 can compensate for the loss of
Bmp4/7, we generated Mef2c-Cre;Bmp4/7f/f;miR-17-92OE/+
embryos. Mesenchymal cushion formation was observed in the
OFT of Mef2c-Cre;Bmp4/7f/f;miR-17-92OE/+ embryos (Fig. 5E,F):
proximal cushion-forming cells were observed in 83% of the
embryos, whereas distal cushion cells were observed in all embryos
examined (Table 2). At E14.5, the valve defect of Bmp4/7 dCKO
embryos was rescued by overexpression of miR-17-92, and OFT
septation was partially rescued in the distal part (data not shown).
The level of Vegfa in Mef2c-Cre;Bmp4/7f/f;miR-17-92OE/+ embryos
was decreased compared with Mef2c-Cre;Bmp4/7f/f and comparable
to that of control embryos (Fig. 5B), suggesting that suppression of
Vegfa by Bmp was mediated by miR-17 and miR-20a. These results
strongly suggest that miR-17 and miR-20a are downstream effectors
of the Bmp signal during OFT development.
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Fig. 3. miR-17/20a are downstream effectors of Bmp
signaling. (A) Analysis of the Vegfa 3UTR reveals a highly
conserved miR-17/20a binding site (boxed). Species
abbreviations as Fig. 2. (B) qRT-PCR analysis of pri-miR-17-
92, miR-17 and miR-20a in the OFT of Bmp4/7 dCKO
mouse embryos. *P=0.049, **P=0.027 (two-tailed t-test).
Control, n=5; mutant, n=3. (C-F) Histological analysis of
miR-17-92 null embryos at E10.5 (C,D) and E14.5 (E,F).
Black arrowhead indicates a proximal EMT defect at E10.5
(D). White arrowheads indicate a distal EMT defect (D)
and abnormal semilunar valve at E14.5 (F). See Fig. 1 for
labels. (G) qRT-PCR analysis of Vegfa in the OFT of the
miR-17-92 mutant. Control, n=4; mutant, n=4. *P=0.046
(two-tailed t-test). (H) (Top) Binding of miR-17/20a seed
sequences to the Vegfa 3UTR. (Middle) Vegfa 3UTR
luciferase reporter construct. (Bottom) Mutation of seed
sequences. (I) Luciferase assay performed by transfecting
reporter construct and miR-17 or miR-20a. miR-92a was
used as a negative control. *P=0.032, **P=0.009 (two-












Although cushion formation was observed in Mef2c-
Cre;Bmp4/7f/f;miR-17-92OE/+ embryos, there were fewer
mesenchymal cushion-forming cells in the rescued embryos,
indicating partial suppression (Fig. 5C-F). In addition, the extent
of mesenchymal cushion formation was variable (Fig. 5C-F,
Table 2). Together, these data support the hypothesis that Bmp
signals are mediated by effector mechanisms in addition to 
miR-17.
DISCUSSION
Our data uncover a direct interaction between the Bmp and Vegfa
signaling pathways that are important for normal OFT development.
Moreover, our findings uncover a mechanism to tightly modulate
Vegfa activity levels in the OFT. Our results also provide new
insight into the mechanism for coordinated development of CNC
and endocardial cells as they contribute to the conotruncal cushions.
Lastly, our data reveal that miR-17-92 indirectly, via non-cell-
autonomous mechanisms, regulates CNC development in addition
to that of SHF-derived tissues.
Coordinated regulation of cushion formation
derived from multiple cell types
The conotruncal cushions are derived from both CNC and the
endocardium. Bmp signaling has been implicated previously in
EMT within the AVC. We now show that Bmp signaling is also
important for EMT within the OFT. Previous data in the AVC
indicate that Bmp regulates genes such as Twist and Snai1 to
promote EMT and, although we did not focus on that mechanism
here, it is likely that similar mechanisms are at work in both the
OFT and AVC. Our finding that Bmp signaling negatively
regulates Vegfa in the OFT provides important insight into the
coordinated regulation of the OFT cushions. In the OFT, in
contrast to the AVC, there are three separate tissues developing 
in close proximity: myocardium, endocardium and CNC. We
provide evidence that Vegfa repression mediated by Bmp–miR-
17-92 is a crucial mechanism to ensure coordinated OFT
development.
The importance of Vegf signaling in endocardium has recently
been demonstrated. Deleting the Vegf receptor neuropilin 1 (Nrp1)
RESEARCH ARTICLE Development 140 (16)
Fig. 4. Ex vivo collagen gel assay of EMT in the OFT. (A) Outline
of the OFT explant culture on collagen gel. The OFT from an E10.5
mouse embryo was dissected, cut, and placed on the collagen gel.
The inner endocardium layer (green) was exposed to the gel, with
the myocardium (blue) on the top. lv, left ventricle; rv, right
ventricle; oft, outflow tract. (B-K) EMT assays on the OFT of control,
Bmp4/7 dCKO, and miR-17-92 null embryos in the presence or
absence of the Vegfa antagonist sFlt. EMT was visualized by
phalloidin to outline the cell shape and by alpha-SMA
immunostaining to stain mesenchymal cells. TOP3 was used to
stain nuclei. Invasive EMT is observed on the surface of the
collagen gel (top row, arrowheads) and non-invasive EMT is
observed in the gel (bottom row, arrowheads). Scale bars: 100 μm.
Fig. 5. Rescue of Bmp4/7 deficiency by conditionally
overexpressing miR-17-92. (A) qPCR analysis of miR-17,
miR-20a and Vegfa expression in the OFT of miR-17-
92OE/+ mouse embryos. miR-106b is used as a negative
control. *P=0.016 (miR-17), *P=0.047 (Vegfa), **P=0.033
(two-tailed t-test). Control, n=4; mutant, n=4. (B) qRT-
PCR analysis of Vegfa expression in Bmp4/7 dCKO and
miR-17-92OE/+ embryos. Control, n=6; Bmp4/7 mutant,
n=5; miR-17-92 mutant, n=3. *P=0.045, **P=0.048 (two-
tailed t-test). All error bars represent s.e.m. 
(C-F) Histological analysis of the OFT of Bmp4/7 dCKO
and miR-17-92 overexpression embryos at E10.5. Black
and white arrowheads indicate proximal and distal OFT
mesenchymal cells, respectively. ba, branchial arch; m,
myocardium; mc, mesenchymal cushion; e, epithelium.
Scale bars: 100 μm. (G) Regulation of OFT development
by Bmp. Solid lines indicate direct regulation; broken











in endocardial cells disrupts OFT development, with abnormal
cushion morphogenesis (Zhou et al., 2012). This indicates that
endocardium is a target cell for Vegf signaling. There are no
previous findings implicating Vegfa signaling in CNC
development. Our data suggest that elevated Vegfa inhibits CNC
influx into the OFT; however, more experiments are required to
confirm this.
A mechanism to tightly modulate Vegfa activity
in the developing heart
Previous genetic studies have shown that the Vegfa dose must be
maintained within a narrow window for normal embryonic
development. Vegfa heterozygosity, as well as small gains in Vegfa
activity, result in defective embryonic development. Loss of a single
Vegfa allele is embryonic lethal at mid-gestation due to impaired
angiogenesis and blood island formation (Ferrara et al., 1996).
Moreover, there are cardiomyoblast differentiation defects in Vegfa
heterozygotes. Haigh et al. found that heterozygous inactivation of
Vegfa using Col2a1-Cre caused lethality at E10.5, with defects in
the myocardial and endocardial layers of the heart (Haigh et al.,
2000). A different Vegfa allele, Vegflo, results in 3-fold
overexpression of Vegfa during development; heterozygotes for this
allele are viable, whereas homozygous embryos die at E9.0 with
dorsal aortae defects and severe abnormalities in yolk sac
vasculature (Damert et al., 2002).
Our data indicate that Vegfa activity in the OFT is concurrently
regulated by Smad transcriptional repression and post-
transcriptional repression by miRNAs. Vegfa has previously been
reported to be regulated by miRNAs, including the miR-17 family,
in other contexts including cultured breast cancer cells and diabetes
(Cascio et al., 2010; Long et al., 2010). However, our finding that
miRNA regulation cooperates with Smad-mediated repression
provides new insight into the mechanisms underlying tight Vegfa
dosage regulation.
Bmp interacts with calcineurin-NFAT signaling
Previous work indicated that Nfatc1 mutants have conotruncal
valve phenotypes similar to those of a Mef2c-Cre;Bmp2/4/7 triple
mutant (Y.B. and J.F.M., unpublished). Moreover, similar to what
we have discovered for Bmp signaling, Nfatc1 inhibits Vegfa
expression in the E9.5 OFT to permit EMT (Chang et al., 2004;
Stankunas et al., 2010). Nfatc1 expression is reduced in the AV
cushion endocardium of Bmp2 conditional mutant embryos (Ma et
al., 2005). There is evidence from pulmonary vascular cells that
NFAT and Bmp are in a linear genetic pathway (Chan et al., 2011).
Other intriguing data indicate that NFAT can promote
chondrogenesis in vitro, a known function for Bmp signaling
(Tomita et al., 2002). More work will be required to reveal
potential interactions between calcineurin-NFAT and Bmp
signaling in the developing OFT.
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